Qilu Pharmaceutical
FDA Approved Drugs

Qilu Pharmaceutical

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 36
  • Latest Approval Date Sep 15, 2025
  • Data Source FDA
  • First Approval Date Jan 27, 2016
Company Overview

Company

Qilu Pharmaceutical

Country

China

Website

Visit Website

Email

export@qilu-pharma.com

Social Profiles

Company Snapshot

Qilu Pharmaceutical

No.8888, Youyou Road, High-tech Zone, Jinan City, Shandong Province

China

www.qilu-pharma.com/ export@qilu-pharma.com View on Map
FDA Approved Drug Records ( 36 records )
2019
27 Sep
RX Application: 212462

Drug Name

ABIRATERONE ACETATE

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2019-09-27

212462 / 1

Active Ingredient

ABIRATERONE ACETATE

Application Number

212462

Product Number

1

Dosage Form

-

Strength

250MG

Approval Date

2019-09-27

Regulatory Status

RX

2021
25 Jun
RX Application: 212462

Drug Name

ABIRATERONE ACETATE

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2021-06-25

212462 / 2

Active Ingredient

ABIRATERONE ACETATE

Application Number

212462

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

2021-06-25

Regulatory Status

RX

2024
19 Mar
RX Application: 218146

Drug Name

AMIKACIN SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/ML

Approval Date

2024-03-19

218146 / 1

Active Ingredient

AMIKACIN SULFATE

Application Number

218146

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/ML

Approval Date

2024-03-19

Regulatory Status

RX

2024
16 Apr
RX Application: 217776

Drug Name

CETRORELIX ACETATE

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/VIAL

Approval Date

2024-04-16

217776 / 1

Active Ingredient

CETRORELIX ACETATE

Application Number

217776

Product Number

1

Dosage Form

-

Strength

EQ 0.25MG BASE/VIAL

Approval Date

2024-04-16

Regulatory Status

RX

2024
10 May
RX Application: 218868

Drug Name

CISPLATIN

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2024-05-10

218868 / 1

Active Ingredient

CISPLATIN

Application Number

218868

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2024-05-10

Regulatory Status

RX

2025
15 Sep
RX Application: 219049

Drug Name

CYCLOSPORINE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2025-09-15

219049 / 1

Active Ingredient

CYCLOSPORINE

Application Number

219049

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2025-09-15

Regulatory Status

RX

2025
15 Sep
RX Application: 219049

Drug Name

CYCLOSPORINE

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2025-09-15

219049 / 2

Active Ingredient

CYCLOSPORINE

Application Number

219049

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

2025-09-15

Regulatory Status

RX

2020
13 Apr
RX Application: 213547

Drug Name

EXEMESTANE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-04-13

213547 / 1

Active Ingredient

EXEMESTANE

Application Number

213547

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-04-13

Regulatory Status

RX

2025
23 Apr
RX Application: 218855

Drug Name

GANIRELIX ACETATE

Product Number

1

Dosage Form

-

Strength

250MCG/0.5ML

Approval Date

2025-04-23

218855 / 1

Active Ingredient

GANIRELIX ACETATE

Application Number

218855

Product Number

1

Dosage Form

-

Strength

250MCG/0.5ML

Approval Date

2025-04-23

Regulatory Status

RX

2024
06 Mar
RX Application: 218021

Drug Name

HYDROXYUREA

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2024-03-06

218021 / 1

Active Ingredient

HYDROXYUREA

Application Number

218021

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2024-03-06

Regulatory Status

RX

2024
20 Nov
RX Application: 218899

Drug Name

ICOSAPENT ETHYL

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2024-11-20

218899 / 1

Active Ingredient

ICOSAPENT ETHYL

Application Number

218899

Product Number

1

Dosage Form

-

Strength

1GM

Approval Date

2024-11-20

Regulatory Status

RX

2024
22 Feb
RX Application: 217265

Drug Name

LENALIDOMIDE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2024-02-22

217265 / 1

Active Ingredient

LENALIDOMIDE

Application Number

217265

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2024-02-22

Regulatory Status

RX

2024
22 Feb
RX Application: 217265

Drug Name

LENALIDOMIDE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2024-02-22

217265 / 2

Active Ingredient

LENALIDOMIDE

Application Number

217265

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2024-02-22

Regulatory Status

RX

2024
22 Feb
RX Application: 217265

Drug Name

LENALIDOMIDE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2024-02-22

217265 / 3

Active Ingredient

LENALIDOMIDE

Application Number

217265

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2024-02-22

Regulatory Status

RX

2024
22 Feb
RX Application: 217265

Drug Name

LENALIDOMIDE

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2024-02-22

217265 / 4

Active Ingredient

LENALIDOMIDE

Application Number

217265

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2024-02-22

Regulatory Status

RX

2024
22 Feb
RX Application: 217265

Drug Name

LENALIDOMIDE

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2024-02-22

217265 / 5

Active Ingredient

LENALIDOMIDE

Application Number

217265

Product Number

5

Dosage Form

-

Strength

20MG

Approval Date

2024-02-22

Regulatory Status

RX

2024
22 Feb
RX Application: 217265

Drug Name

LENALIDOMIDE

Product Number

6

Dosage Form

-

Strength

25MG

Approval Date

2024-02-22

217265 / 6

Active Ingredient

LENALIDOMIDE

Application Number

217265

Product Number

6

Dosage Form

-

Strength

25MG

Approval Date

2024-02-22

Regulatory Status

RX

2024
22 Jul
RX Application: 216424

Drug Name

MEROPENEM

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2024-07-22

216424 / 1

Active Ingredient

MEROPENEM

Application Number

216424

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2024-07-22

Regulatory Status

RX

2024
22 Jul
RX Application: 216424

Drug Name

MEROPENEM

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2024-07-22

216424 / 2

Active Ingredient

MEROPENEM

Application Number

216424

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2024-07-22

Regulatory Status

RX

2025
30 Jun
RX Application: 217989

Drug Name

MIRABEGRON

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2025-06-30

217989 / 1

Active Ingredient

MIRABEGRON

Application Number

217989

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2025-06-30

Regulatory Status

RX

2025
30 Jun
RX Application: 217989

Drug Name

MIRABEGRON

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2025-06-30

217989 / 2

Active Ingredient

MIRABEGRON

Application Number

217989

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2025-06-30

Regulatory Status

RX

2016
27 Jan
RX Application: 204319

Drug Name

OLANZAPINE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2016-01-27

204319 / 1

Active Ingredient

OLANZAPINE

Application Number

204319

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204319

Drug Name

OLANZAPINE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2016-01-27

204319 / 2

Active Ingredient

OLANZAPINE

Application Number

204319

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204319

Drug Name

OLANZAPINE

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2016-01-27

204319 / 3

Active Ingredient

OLANZAPINE

Application Number

204319

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204319

Drug Name

OLANZAPINE

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2016-01-27

204319 / 4

Active Ingredient

OLANZAPINE

Application Number

204319

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204319

Drug Name

OLANZAPINE

Product Number

5

Dosage Form

-

Strength

15MG

Approval Date

2016-01-27

204319 / 5

Active Ingredient

OLANZAPINE

Application Number

204319

Product Number

5

Dosage Form

-

Strength

15MG

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204319

Drug Name

OLANZAPINE

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2016-01-27

204319 / 6

Active Ingredient

OLANZAPINE

Application Number

204319

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2016-01-27

Regulatory Status

RX

2025
16 May
RX Application: 218116

Drug Name

OLANZAPINE

Product Number

1

Dosage Form

-

Strength

10MG/VIAL

Approval Date

2025-05-16

218116 / 1

Active Ingredient

OLANZAPINE

Application Number

218116

Product Number

1

Dosage Form

-

Strength

10MG/VIAL

Approval Date

2025-05-16

Regulatory Status

RX

2019
10 Jan
RX Application: 210552

Drug Name

OLMESARTAN MEDOXOMIL

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-01-10

210552 / 1

Active Ingredient

OLMESARTAN MEDOXOMIL

Application Number

210552

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-01-10

Regulatory Status

RX

2019
10 Jan
RX Application: 210552

Drug Name

OLMESARTAN MEDOXOMIL

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2019-01-10

210552 / 2

Active Ingredient

OLMESARTAN MEDOXOMIL

Application Number

210552

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2019-01-10

Regulatory Status

RX

2019
10 Jan
RX Application: 210552

Drug Name

OLMESARTAN MEDOXOMIL

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2019-01-10

210552 / 3

Active Ingredient

OLMESARTAN MEDOXOMIL

Application Number

210552

Product Number

3

Dosage Form

-

Strength

40MG

Approval Date

2019-01-10

Regulatory Status

RX

2019
20 May
RX Application: 209333

Drug Name

SOLIFENACIN SUCCINATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-05-20

209333 / 1

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

209333

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2019-05-20

Regulatory Status

RX

2019
20 May
RX Application: 209333

Drug Name

SOLIFENACIN SUCCINATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-05-20

209333 / 2

Active Ingredient

SOLIFENACIN SUCCINATE

Application Number

209333

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2019-05-20

Regulatory Status

RX

2018
02 Mar
RX Application: 209498

Drug Name

TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-03-02

209498 / 1

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Application Number

209498

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2018-03-02

Regulatory Status

RX

2018
02 Mar
RX Application: 209498

Drug Name

TENOFOVIR DISOPROXIL FUMARATE

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2018-03-02

209498 / 2

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Application Number

209498

Product Number

2

Dosage Form

-

Strength

250MG

Approval Date

2018-03-02

Regulatory Status

RX

2018
02 Mar
RX Application: 209498

Drug Name

TENOFOVIR DISOPROXIL FUMARATE

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2018-03-02

209498 / 3

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Application Number

209498

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

2018-03-02

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    19 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    36 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
36 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABIRATERONE ACETATE

Application Number

212462

Product Number

1

Active Ingredient

ABIRATERONE ACETATE

Dosage Form

-

Strength

250MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit